Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Pluristyx and Qkine Announce a Reciprocal Distribution Agreement in Support of Optimized Growth Factor Differentiation of Induced Pluripotent Stem Cell (iPSC)

May 1, 2026

Poultry Processing Equipment Market Analysis Report 2026: $6.37 Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

May 1, 2026

Rituximab Biosimilars Market Trastuzumab Biosimilars Market Research Analysis Report 2026: $6.2 Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

May 1, 2026

Trastuzumab Biosimilars Market Analysis Report 2026: $24.48 Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

May 1, 2026

CereAura Aims to Simplify Autism Diagnosis and Therapy Through AI-Driven Insights

May 1, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Faruqi & Faruqi Reminds Five Below Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 30, 2024 – FIVE
Press Release

Faruqi & Faruqi Reminds Five Below Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 30, 2024 – FIVE

By News RoomSeptember 13, 20243 Mins Read
Faruqi & Faruqi Reminds Five Below Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 30, 2024 – FIVE
Share
Facebook Twitter LinkedIn Pinterest Email

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Five Below To Contact Him Directly To Discuss Their Options

If you suffered losses exceeding $100,000 investing in Five Below stock or options between March 20, 2024 and July 16, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

[You may also click here for additional information]

NEW YORK, Sept. 13, 2024 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Five Below, Inc. (“Five Below” or the “Company”) (NASDAQ: FIVE) and reminds investors of the September 30, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.

As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: Defendants provided investors with false and/or materially misleading information about FIVE’s financial strength and operations, including its outlook for the first quarter and full year 2024. This information included FIVE’s statement that net sales are expected to be in the range of $826 million to $846 million based on opening approximately 55 to 60 new stores in the first quarter. Further, FIVE claimed that net sales for the full year are expected to be in the range of $3.97 billion to $4.07 billion based on opening between 225 and 235 new stores.

On July 16, 2024, Five Below announced the resignation of Joel Anderson from his positions as President and Chief Executive Officer, as well as from his seat on the Company’s Board of Directors. Concurrently, Five Below projected a decrease of 6% to 7% in comparable sales for the fiscal second quarter ending August 3, 2024.

On this news, Five Below’s stock price fell $25.57 per share, or 25.05%, to close at $76.50 per share on July 17, 2024.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.  

Faruqi & Faruqi, LLP also encourages anyone with information regarding Five Below’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

To learn more about the Five Below class action, go to www.faruqilaw.com/FIVE or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

Follow us for updates on LinkedIn, on X, or on Facebook.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/88027245-91ee-4c83-a2e2-f4a603c50460

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Pluristyx and Qkine Announce a Reciprocal Distribution Agreement in Support of Optimized Growth Factor Differentiation of Induced Pluripotent Stem Cell (iPSC)

Poultry Processing Equipment Market Analysis Report 2026: $6.37 Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Rituximab Biosimilars Market Trastuzumab Biosimilars Market Research Analysis Report 2026: $6.2 Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Trastuzumab Biosimilars Market Analysis Report 2026: $24.48 Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

CereAura Aims to Simplify Autism Diagnosis and Therapy Through AI-Driven Insights

AITRADEBTC Introduces AiTradeBtc Automated Cryptocurrency Trading Platform

The Rise of AI-Native Financial Infrastructure: Google Cloud & DeepX Launched Collaborative Litepaper

Magna Announces Strong First Quarter Results; Maintains Positive Outlook for 2026

Pepperstone Joins FX168 to Strengthen Global Institutional Connectivity and Accelerate the SFFE2030 Ecosystem

Editors Picks

Poultry Processing Equipment Market Analysis Report 2026: $6.37 Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

May 1, 2026

Rituximab Biosimilars Market Trastuzumab Biosimilars Market Research Analysis Report 2026: $6.2 Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

May 1, 2026

Trastuzumab Biosimilars Market Analysis Report 2026: $24.48 Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

May 1, 2026

CereAura Aims to Simplify Autism Diagnosis and Therapy Through AI-Driven Insights

May 1, 2026

Latest News

AITRADEBTC Introduces AiTradeBtc Automated Cryptocurrency Trading Platform

May 1, 2026

The Rise of AI-Native Financial Infrastructure: Google Cloud & DeepX Launched Collaborative Litepaper

May 1, 2026

Magna Announces Strong First Quarter Results; Maintains Positive Outlook for 2026

May 1, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version